196 related articles for article (PubMed ID: 31010812)
1. CD4
Rapaka RR; Dai G; Zheng M; Kolls JK
Infect Immun; 2019 Jul; 87(7):. PubMed ID: 31010812
[No Abstract] [Full Text] [Related]
2. Conserved natural IgM antibodies mediate innate and adaptive immunity against the opportunistic fungus Pneumocystis murina.
Rapaka RR; Ricks DM; Alcorn JF; Chen K; Khader SA; Zheng M; Plevy S; Bengtén E; Kolls JK
J Exp Med; 2010 Dec; 207(13):2907-19. PubMed ID: 21149550
[TBL] [Abstract][Full Text] [Related]
3. The Trophic Life Cycle Stage of the Opportunistic Fungal Pathogen Pneumocystis murina Hinders the Ability of Dendritic Cells To Stimulate CD4
Evans HM; Simpson A; Shen S; Stromberg AJ; Pickett CL; Garvy BA
Infect Immun; 2017 Oct; 85(10):. PubMed ID: 28694293
[TBL] [Abstract][Full Text] [Related]
4. Eosinophils Contribute to Early Clearance of Pneumocystis murina Infection.
Eddens T; Elsegeiny W; Nelson MP; Horne W; Campfield BT; Steele C; Kolls JK
J Immunol; 2015 Jul; 195(1):185-93. PubMed ID: 25994969
[TBL] [Abstract][Full Text] [Related]
5. Role of type I IFNs in pulmonary complications of Pneumocystis murina infection.
Meissner NN; Swain S; Tighe M; Harmsen A; Harmsen A
J Immunol; 2005 May; 174(9):5462-71. PubMed ID: 15843544
[TBL] [Abstract][Full Text] [Related]
6. B cell and antibody responses in mice induced by a putative cell surface peptidase of Pneumocystis murina protect against experimental infection.
Ruan S; Cai Y; Ramsay AJ; Welsh DA; Norris K; Shellito JE
Vaccine; 2017 Jan; 35(4):672-679. PubMed ID: 28012778
[TBL] [Abstract][Full Text] [Related]
7. Treatment with Interleukin-7 Restores Host Defense against Pneumocystis in CD4+ T-Lymphocyte-Depleted Mice.
Ruan S; Samuelson DR; Assouline B; Morre M; Shellito JE
Infect Immun; 2016 Jan; 84(1):108-19. PubMed ID: 26483405
[TBL] [Abstract][Full Text] [Related]
8. Dectin immunoadhesins and pneumocystis pneumonia.
Ricks DM; Chen K; Zheng M; Steele C; Kolls JK
Infect Immun; 2013 Sep; 81(9):3451-62. PubMed ID: 23836814
[TBL] [Abstract][Full Text] [Related]
9. Oral Immunization of Mice with Live Pneumocystis murina Protects against Pneumocystis Pneumonia.
Samuelson DR; de la Rua NM; Charles TP; Ruan S; Taylor CM; Blanchard EE; Luo M; Ramsay AJ; Shellito JE; Welsh DA
J Immunol; 2016 Mar; 196(6):2655-65. PubMed ID: 26864029
[TBL] [Abstract][Full Text] [Related]
10. Intranasal immunization confers protection against murine Pneumocystis carinii lung infection.
Pascale JM; Shaw MM; Durant PJ; Amador AA; Bartlett MS; Smith JW; Gregory RL; McLaughlin GL
Infect Immun; 1999 Feb; 67(2):805-9. PubMed ID: 9916094
[TBL] [Abstract][Full Text] [Related]
11. Effect of Subcutaneous Anti-CD20 Antibody-Mediated B Cell Depletion on Susceptibility to Pneumocystis Infection in Mice.
Dai G; Noell K; Weckbecker G; Kolls JK
mSphere; 2021 May; 6(3):. PubMed ID: 33952667
[TBL] [Abstract][Full Text] [Related]
12. Clearance of Pneumocystis carinii in mice is dependent on B cells but not on P carinii-specific antibody.
Lund FE; Schuer K; Hollifield M; Randall TD; Garvy BA
J Immunol; 2003 Aug; 171(3):1423-30. PubMed ID: 12874234
[TBL] [Abstract][Full Text] [Related]
13. B cells modulate systemic responses to Pneumocystis murina lung infection and protect on-demand hematopoiesis via T cell-independent innate mechanisms when type I interferon signaling is absent.
Hoyt TR; Dobrinen E; Kochetkova I; Meissner N
Infect Immun; 2015 Feb; 83(2):743-58. PubMed ID: 25452554
[TBL] [Abstract][Full Text] [Related]
14. B cell production of tumor necrosis factor in response to Pneumocystis murina infection in mice.
Opata MM; Ye Z; Hollifield M; Garvy BA
Infect Immun; 2013 Nov; 81(11):4252-60. PubMed ID: 24002064
[TBL] [Abstract][Full Text] [Related]
15. Memory CD4+ T cells are required for optimal NK cell effector functions against the opportunistic fungal pathogen Pneumocystis murina.
Kelly MN; Zheng M; Ruan S; Kolls J; D'Souza A; Shellito JE
J Immunol; 2013 Jan; 190(1):285-95. PubMed ID: 23203926
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory responses to Pneumocystis carinii in mice selectively depleted of helper T lymphocytes.
Beck JM; Warnock ML; Curtis JL; Sniezek MJ; Arraj-Peffer SM; Kaltreider HB; Shellito JE
Am J Respir Cell Mol Biol; 1991 Aug; 5(2):186-97. PubMed ID: 1679991
[TBL] [Abstract][Full Text] [Related]
17. Enhanced defense against Pneumocystis carinii mediated by a novel dectin-1 receptor Fc fusion protein.
Rapaka RR; Goetzman ES; Zheng M; Vockley J; McKinley L; Kolls JK; Steele C
J Immunol; 2007 Mar; 178(6):3702-12. PubMed ID: 17339468
[TBL] [Abstract][Full Text] [Related]
18. Pneumocystis murina colonization in immunocompetent surfactant protein A deficient mice following environmental exposure.
Linke MJ; Ashbaugh AD; Demland JA; Walzer PD
Respir Res; 2009 Feb; 10(1):10. PubMed ID: 19228388
[TBL] [Abstract][Full Text] [Related]
19. Combination exposure to zidovudine plus sulfamethoxazole-trimethoprim diminishes B-lymphocyte immune responses to Pneumocystis murina infection in healthy mice.
Feola DJ; Garvy BA
Clin Vaccine Immunol; 2006 Feb; 13(2):193-201. PubMed ID: 16467325
[TBL] [Abstract][Full Text] [Related]
20. Lymphocytes in host defense against Pneumocystis carinii.
Beck JM; Harmsen AG
Semin Respir Infect; 1998 Dec; 13(4):330-8. PubMed ID: 9872630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]